KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Assets (2018 - 2025)

Twist Bioscience (TWST) has disclosed Assets for 8 consecutive years, with $638.1 million as the latest value for Q4 2025.

  • Quarterly Assets rose 4.85% to $638.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $638.1 million through Dec 2025, up 4.85% year-over-year, with the annual reading at $641.9 million for FY2025, 4.48% up from the prior year.
  • Assets for Q4 2025 was $638.1 million at Twist Bioscience, down from $641.9 million in the prior quarter.
  • The five-year high for Assets was $1.0 billion in Q1 2022, with the low at $595.6 million in Q1 2025.
  • Average Assets over 5 years is $751.0 million, with a median of $714.1 million recorded in 2021.
  • The sharpest move saw Assets skyrocketed 109.12% in 2021, then decreased 21.25% in 2024.
  • Over 5 years, Assets stood at $786.2 million in 2021, then increased by 15.75% to $910.0 million in 2022, then decreased by 19.47% to $732.8 million in 2023, then decreased by 16.95% to $608.6 million in 2024, then increased by 4.85% to $638.1 million in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $638.1 million, $641.9 million, and $643.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.